Be aware of malaria
With World Malaria Day on April 25, raising awareness about malaria is crucial.
According to Affinity Health, this life-threatening disease continues to be a major public health concern, especially in high-risk areas.
'According to the World Health Organisation (WHO), millions of people worldwide are affected yearly, with Africa experiencing the highest number of cases. While malaria is both preventable and treatable, delaying diagnosis and treatment can lead to severe complications such as organ failure and even death,' says Murray Hewlett, CEO of Affinity Health.
'The Plasmodium parasite causes malaria and spreads through bites from infected female Anopheles mosquitoes.'
Recognising malaria symptoms early and getting medical help right away can save lives. Symptoms typically appear 10–15 days after a mosquito bite, though sometimes they take longer. Since malaria can feel like the flu, it's easy to overlook the warning signs.
Look for these key symptoms:
1. High fever and chills
A sudden onset of fever (often exceeding 38°C) accompanied by intense chills is one of the most common signs of malaria.
2. Excessive sweating
After fever and chills, malaria can cause intense sweating as the body tries to lower its temperature.
3. Headaches and body aches
Malaria often causes intense headaches and aching muscles, especially in the joints and throughout the body.
4. Nausea, vomiting, and diarrhoea
Gastrointestinal symptoms can accompany malaria, making it easy to mistake for other common infections.
5. Rapid breathing and increased heart rate
As malaria progresses, it can lead to respiratory distress and cardiovascular strain.
6. Extreme tiredness and weakness
Malaria drains the body's energy, causing severe fatigue, drowsiness, and overall weakness.
7. Yellow skin and anaemia
In severe cases, malaria can break down red blood cells, leading to jaundice (yellowing of the skin and eyes) and anaemia, which causes weakness and dizziness.
When to seek medical help
If you or a loved one experiences any of the symptoms listed above, especially after a recent travel to a malaria-prone area, seek medical attention immediately. Early diagnosis and treatment are key to preventing complications.
People are urged not to ignore fever and flu-like symptoms, especially during peak malaria seasons. Diagnostic tests, such as rapid malaria and blood smears, can detect malaria parasites early, allowing prompt treatment.
Who is most at risk?
While malaria can affect anyone, certain groups are at a higher risk of severe illness, including:
Young children: Their immune systems are underdeveloped to fight the parasite.
Pregnant women: Malaria increases the risk of complications for both mother and baby.
Travellers from non-endemic areas: Those without prior exposure lack natural immunity.
Weakened immune systems: This includes people with chronic illnesses such as HIV/AIDS, who are more vulnerable to malaria.
Prevention is better than cure
The best way to lower the risk of malaria is to prevent mosquito bites and stop them from breeding.
Here are some key prevention tips:
Use mosquito nets: Sleeping under insecticide-treated bed nets provides a strong layer of protection.
Apply insect repellents: Use mosquito repellents containing DEET, picaridin, or lemon eucalyptus oil.
Dress for protection: Wear long sleeves, pants, and socks, especially at night, to keep mosquitoes from biting exposed skin.
Get rid of still water: Mosquitoes lay eggs in stagnant water, so regularly check your home and empty any standing water to prevent them from breeding.
Take preventive medication: If travelling to high-risk areas, consult a healthcare provider for malaria prophylaxis.
Conclusion
Affinity Health urges South Africans to prioritise awareness, prevention, and early detection. Malaria is a serious but preventable disease, and taking the proper steps can make all the difference.
At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Eyewitness News
12 hours ago
- Eyewitness News
Gauteng DSD: No jobs in HIV and AIDS programme will be lost despite R108m budget shortfall
JOHANNESBURG - Gauteng's Department of Social Development is facing a R108 million shortfall in its HIV and AIDS programme budget, but officials insist no jobs will be lost. Treasury has slashed funding to R332 million in 2025, down from R440 million, forcing the department to restructure operations while trying to protect services for vulnerable groups. The commitment? To keep social workers, community carers and child and youth care workers employed and to continue funding non-profits supporting those affected by HIV. The department said all psycho-social services — including those offered to orphans, vulnerable children and HIV-positive households — will continue uninterrupted. Those who deliver them — including auxiliary social workers and registered community carers — will remain on payroll. Food relief, however, will now be handled centrally through distribution centres run by the sustainable livelihoods unit as part of a move to streamline resources. The department argues this shift will still prioritise households with no income and is part of a longer-term strategy to capacitate communities instead of relying on ongoing aid. And while incentive grant funding for work opportunities through the Expanded Public Works Programme (EPWP) has dropped dramatically since 2023, social development says job numbers have been maintained, thanks to reallocation from its main budget.
Mail & Guardian
2 days ago
- Mail & Guardian
Close the global healthcare gap: Solutions for a more equitable future
Newborn children in sub-Saharan Africa are 14 times more likely to die within the first month than those in high-income regions such as Australia and New Zealand. Despite decades of advancements, healthcare disparities remain a pressing global concern. Established markets benefit from sophisticated health systems, yet billions of people in low- and middle-income countries still lack access to basic medical services and medical advancements. This inequality can be found in various areas, including access to medication and general healthcare. Considered action must be taken by both public and private agencies to bridge this chasm and create sustainable, equitable healthcare systems that serve patients as effectively in emerging markets as they do in more established parts of the world. In emerging markets, however, infectious diseases such as malaria, tuberculosis (TB) and HIV/Aids continue to be of the utmost concern and child mortality rates vary significantly between emerging and established countries. According to the World Health Organisation, the global under-five mortality rate dropped by 59% from 1990 to 2023, but the disparities remain. Newborn children in sub-Saharan Africa are 14 times more likely to die within the first month than those in high-income regions such as Australia and New Zealand. Treatable diseases in emerging markets continue to claim higher mortality rates than should be expected, because of financial barriers, supply shortages and limited access to trained professionals, resulting from geographical and cost factors. About half the world's population lacks essential health services, leaving billions of people vulnerable to preventable conditions. The World Health Organisation has predicted that, by 2035, there will be a shortage of 12.9 million health workers and this paucity could be most pronounced in lower-income countries because more attractive pay levels will attract medical personnel to higher-income countries. These countries would also be better placed to produce such graduates. Aid organisations based in high-income countries are, however, making great strides in assisting emerging markets, by providing essential supplies, funding and expertise, to facilitate greater access to medication, and fortify the health infrastructure of these regions. The Global Fund to Fight Aids, Tuberculosis and Malaria has, for example, has saved over 65 million lives since its inception in 2002, by achieving a 61% reduction in combined death rates from these diseases. In 2023 alone, the fund supported 25 million people by providing antiretroviral therapy for HIV. They also enabled treatment for 7.1 million TB patients and distributed 227 million mosquito nets, in their quest to reduce malaria infections. Facilities in lower-income countries are fewer in number, poorly equipped and are not likely to exist in rural areas with lower population density. This leaves many patients having to travel long distances for treatment. In contrast, people in high-income countries are closer to hospitals, which are also better equipped. It's noteworthy that higher-income countries invest up to 60 times more per capita in healthcare than lower-income countries do. These financial constraints often force individuals in emerging markets to pay for their care out of their own pockets, which can lead to economic hardship and perpetuate cycles of poverty. Expanding universal health coverage is therefore vital. Countries such as Thailand have successfully implemented universal health coverage policies and these have dramatically reduced financial burdens while improving public health outcomes. Effective governance is critical to strengthening healthcare systems. Of the $7.5 trillion spent globally on health each year, it has been estimated that $500 billion is lost to corruption. In fact, the amount of healthcare funds stolen each year is more than enough to achieve health coverage for all. Tackling these issues through transparency and stronger policy frameworks, including stringent auditing, will significantly improve medical service delivery. Innovative technology-driven solutions also offer us a promising avenue to narrow disparities. Telemedicine has revolutionised healthcare in underserved regions, allowing remote consultation and diagnosis, particularly in areas where medical professionals are scarce. And mobile health (or 'mHealth'), which uses smartphones, has enabled community health workers to track immunisations, disseminate health information and report and track outbreaks. Portable, lower-cost diagnostics have proven to be a further gamechanger. Rapid diagnostic testing devices allow for the immediate diagnosis and treatment of malaria, HIV and TB, although desirable market penetration has yet to be achieved. And then there's artificial intelligence, which is making its presence felt in all fields of human endeavour. AI-powered health-management information systems have different functions — operational, informational and decision-making — which sometimes conflict, but this reflects real-world conditions, where different sectors have to compete for resources. It does, however, give a clear picture of the 'state of play' of a country's health system, which would allow its government to strengthen its healthcare strategy. There is the caveat, however, that internationally agreed recommendations be put in place to avoid possible innate AI bias. Of course, at the foundation of all such progress is the need for infrastructural development. Expanding health worker education is vital and we need to develop initiatives which focus on task shifting, where lower-cadre workers are trained to handle medical tasks, enhancing healthcare delivery efficiency. Community health workers are proving particularly effective in preventative care, offering localised and accessible health support. To make lasting improvements, public-private partnerships must also be used. Many countries have successfully engaged private firms to manage hospitals, expand telehealth networks and supply medication under government contracts. These partnerships inject essential energy, resources, innovation, efficiency and, importantly, accountability into public health systems. Closing the healthcare gap requires a comprehensive, multi-sector approach — one which, fortunately, is already underway. Government investment in universal health coverage, healthcare infrastructure, trained professionals and technological advancements is essential. With the right strategies and private-public commitment, a future where healthcare is accessible and equitable for all can become a reality. All interested parties must, however, exert and maintain the pressure and interest that's required to move all involved bureaucracies forward. Our plan for some imagined tomorrow needs to be replaced by viable action for a literal tomorrow. Asgar Rangoonwala is the senior vice-president of Johnson & Johnson EMEA emerging markets.
TimesLIVE
2 days ago
- TimesLIVE
It's the ‘Donald disease' that's making us sick
As stakeholders duke it out, those with most to lose from HIV funding cuts tell Bhekisisa they have been left to fend for themselves — bad news for all of us By 'Hello, sis. How are you? I hope you're fine. I mean, I'm not.' A lot has been going on out there, he told Bhekisisa in the voicemail, one of the many we recently received. 'You know, I'm a gay guy. I have sex with other men, without wearing condoms now, because when I try to fetch them from my local clinic, I'm told I get judged and told I want too many. You know what's happening in our industry,' he said. We will call him Nkosi. Because he has sex with men and because his industry is sex work and because no-one in the small community where he lives knows that he is gay or what he does for work. He even has a 'girlfriend' so people will think he's straight. Sex work has always been a dangerous profession. But ever since the Trump administration stopped most of its HIV funding in February, it's become even more risky. The World Health Organization says gay and bisexual men like Nkosi's chance of contracting HIV through sex is 26 times higher than that of the general population. Male sex workers are even more likely to get infected with the virus. That is what makes sex workers, as well as gay and bisexual men, what researchers call a ' key population ' in the HIV world. Other key populations are transgender people, people who inject drugs, and, in Africa, also young women between the ages of 15 and 24. Because so many new HIV infections happen in these groups, the US government's Aids fund, Pepfar, has, for the past decades, invested most of its funds in programmes working with these groups. But the 12 specialised clinics for key populations, supported by Pepfar, have now been shut down. Gone, too, are their health workers specially trained in how to work without discrimination. Gone is their tailor-made HIV treatment and testing services; their specialised mental health support; and the condoms and lubricants they handed out for protection against HIV and other sexually transmitted infections. Gone are the two-monthly anti-HIV jabs that some of these clinics handed out as part of studies — and the daily anti-HIV pills, which they distributed without judgement. Though government clinics also stock the daily anti-HIV pill, which, if used correctly, can reduce someone's chance of getting HIV through sex to close to 0, people like Nkosi, research shows, are often treated badly by health workers at state clinics, making them wary to return. Preventive medicines like the daily pill are called pre-exposure prophylaxis, or PrEP, because they stop infection by preventing a germ such as HIV from penetrating someone's cells. 'So sometimes I don't have PrEP,' says Nkosi. 'A partner can tell me he is on PrEP, but I don't trust that. Because where is he getting PrEP? Where am I going to get it? The black market? I don't know if it is even the real thing. Is it a counterfeit? Lube? That's another thing — you use everything, anything, as long as it's got jelly in it. The last time I did that I had an itchy penis for a week.' Nkosi calls the domino effect of the Trump administration's decision to pull funding 'the Donald disease, because it is being caused by this guy, one man. It's like crossing the freeway every day the way we're living now. One day, I know I'm gonna die.' What's with key populations? But why is there so much focus on these communities? UNAids says more than half of all new infections in 2022, around the world, came from key populations — and infections don't stay within those groups. 'Even the most self-interested people should be heavily invested in treatment and prevention of these populations,' says Francois Venter, who heads up the health research organisation, Ezintsha, at Wits University. 'There's no clean, magical division between key populations and general populations. It's a Venn diagram of married men sleeping with sex workers, of drug-using populations interacting with your ostensibly innocent kids, gay men with your straight-presenting son, all needing HIV prevention and treatment programmes.' Though we have medicines like PrEP to prevent people from getting infected with HIV and antiretroviral drugs (ARVs) for HIV-infected people, which, if taken correctly, reduce their chance of transmitting the virus to others to 0, having the medications available is just a small part of the solution. What's more difficult is to get medication to people and to convince people to use it, and to use it correctly. Researchers estimate that of South Africa's 8-million people with HIV, 1.1-million are not on treatment. Some of the 1.1-million choose not to start treatment, but an even larger proportion, who do go on treatment, cycle in and out of it Studies, for example, show that getting people to use the anti-HIV pill, also called oral PrEP, each day, has been a struggle — and those who do use it, often don't use it each day. The less often it's used, the less well it works. Moreover, UN targets that South Africa needs to reach by the end of 2025, show that we struggle to convince people who know they're infected with HIV, to take treatment — and stay on it. Researchers estimate that of South Africa's 8-million people with HIV, 1.1-million are not on treatment. Some of the 1.1-million choose not to start treatment, but an even larger proportion, who do go on treatment, cycle in and out of it. Pepfar programmes funded thousands of 'foot soldiers', such as community health workers, adherence counsellors, data collectors and youth workers, who went into communities with mobile clinics to find people who stopped their treatment, or to make ARVs easier to get by making it possible for people to collect their medicine from community halls, shops or private pharmacies close to where they live. That's why having lost at least half of those workers — we're likely to lose the other half at the end of the US financial year in September — is such a tragedy. And why, if we do nothing to replace them, modelling studies show, there's a high chance that we see up to almost 300,000 extra HIV infections over the next four years and a 38% increase in Aids deaths. The difficulty with state clinics and key populations Government clinics are mostly not geared towards key populations, because they serve everyone. And because many health workers' own prejudices so often interfere with the way they treat patients such as sex workers, gay and bisexual men, or teens who ask for condoms or PrEP, such groups frequently feel uncomfortable to use state health services. Stigma and discrimination in public clinics — doled out by security guards, cleaners, health workers and patients in waiting rooms — keep people away from HIV treatment and prevention. Researchers who surveyed more than 9,000 people in key populations found that less than half, and in some cases not even a quarter, said they were treated well; about one in five said they were blocked from getting services. Motsoaledi says he's trying to fix that by now training 1,012 clinicians and 2,377 non-clinician workers at government facilities in non-discriminatory healthcare. But despite similar trainings having been conducted for years already, discrimination remains rife. Because funding cuts mean already understaffed government health clinics now have even fewer staff, many people with HIV, or those wanting PrEP, have to travel further for treatment, or wait in long queues. As politicians, activists and researchers duke it out from labs and clinics and press conferences, many of those most at risk, like Nkosi, have been left to fend for themselves. Here are some of their stories — we collected the stories via voice notes with the help of health workers who worked for Pepfar programmes that have now been defunded. Female sex worker: 'My child is going to be infected' 'Yoh, life is very hard. Since all this happened, life has been very, very hard. 'I have tried to go to the public clinic for my medication. But as sex workers, we are not being helped. We are scared to go to the government clinic to treat sexually transmitted infections because we are seen as dirty people who go and sleep around. We even struggle to get condoms. We are now forced to do business without protection because it is our only source of income and it's the way that we put food on the table. My worry now is that I am pregnant and my child is going to be infected because I'm not taking my ARVs, and I have defaulted for two months now.' Transgender woman: 'The future is dark' 'I'm a transgender woman. My pronouns are she. 'When the clinic closed, I was about to run out of medication so I went to the government clinic in my area. I introduced myself to the receptionist and the lady asked me what kind of treatment I was taking. I told her ARVs and that I'm virally suppressed [when people use their treatment correctly the virus can't replicate, leaving so little virus in their bodies that they can't infect others], so I can't transmit HIV to others. 'The lady told me that they can't help me and I need to bring the transfer letter. I told her that the clinic is closed so I don't have the transfer letter. I asked to speak to the manager and the manager also refused to help me. The manager! How can she let someone who is HIV-positive go home without medication? 'I had to call one of my friends and she gave me one container. If you're not taking your medication consistently, you're going to get sick, you're gonna die. And the future? The future is dark.' Migrant farm worker: 'Lose my job? Or risk my health?' 'When we were told that the clinic was closed, I was actually in another town trying to get a seasonal job on the farms. But when I went to the nearest clinic, I was told that I needed to get a transfer letter. So I ended up sharing medication with friends. But then their medication also ran out. 'Then I got a job on the farm. Before the mobile clinics came to the farms and we had our clinical sessions there. The nurse was there, the social worker was there. Now we went to the clinic and spent the whole day there because we had to follow the queues. And because our jobs were not permanent jobs, you know, you just get a job if you apply by the gate. So if you are not there by the gate on that day, then the boss will automatically think that you are no longer interested in the job, so they employ someone else. 'I went to the government clinic and asked to get at least three months' supply. But the clinic said no because it was my first initiation so I had to come back. So I went back to the farm to see if I could still have my job. I found that I was no longer employed because they had to take up someone else. 'What am I going to do? If I go to the clinic, I stand a chance of losing my job. If I stay at my job I am at risk of getting sick.' Trans woman: 'I'll just stay home and die' 'Accessing treatment is difficult because of the long queues. Even that security guard keeps on telling me to go away when I ask for lubricants and he tells me every time there's no lubricants. 'We need the trans clinic back. I need to speak to somebody, a psychologist. On Tuesdays we had our psychologist come in, and the doctor. But now I don't have the funds to go and see even a psychologist. 'It is bad. It is super bad. I don't know when I last took my meds. Another friend of mine just decided, oh, OK, since the clinic is closed and I no longer have medication, I'll just stay home and die.'
